Raltegravir is an antiretroviral agent used to treat HIV infection. It works by inhibiting the integrase enzyme, preventing viral DNA from integrating into the host genome. Raltegravir is effective in controlling HIV replication. In summary, Raltegravir is beneficial for managing HIV infection.
Raltegravir inhibits HIV integrase, preventing the integration of viral DNA into the host cell's genome and reducing viral replication.
No published brands for this salt yet.